Perrigo downgraded by Piper Sandler with a new price target
$PRGO
Biotechnology: Pharmaceutical Preparations
Health Care
Piper Sandler downgraded Perrigo from Overweight to Neutral and set a new price target of $27.00 from $34.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/14/2025 | Buy → Hold | Argus | |
| 1/6/2025 | $34.00 → $27.00 | Overweight → Neutral | Piper Sandler |
| 9/24/2024 | $50.00 → $30.00 | Hold | Jefferies |
| 11/17/2023 | $37.00 | Overweight | Piper Sandler |
| 3/7/2023 | $49.00 | Buy | Canaccord Genuity |
| 9/14/2022 | $46.00 | Hold → Buy | Argus |
| 9/6/2022 | $48.00 → $54.00 | Equal Weight → Overweight | Wells Fargo |
| 11/11/2021 | $59.00 → $55.00 | Outperform | Raymond James |
Argus downgraded Perrigo from Buy to Hold
Piper Sandler downgraded Perrigo from Overweight to Neutral and set a new price target of $27.00 from $34.00 previously
Jefferies resumed coverage of Perrigo with a rating of Hold and set a new price target of $30.00 from $50.00 previously